secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2026-08-18T20:00:17+00:00
Accession:  0001493152-26-039000
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix appoints CEO Seth Lederman as Interim Chief Medical Officer
-----------------------------------------------------------------

- On Aug 18, 2026, Tonix appointed Dr. Seth Lederman, age 69, as Interim Chief Medical Officer.
- Lederman remains President, CEO, and Chairman; no changes to those roles.
- No arrangements or family relationships noted in the appointment.
- Appointment effective immediately; no compensation changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226039000/0001493152-26-039000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226039000/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer